Company: PSTV
Filing Date: 2025-03-31
Form Type: 10-K
Source: 0000950170-25-047698
Chunk: 8

Company: PLUS THERAPEUTICS, INC.
Filing Date: 2025-03-31
Form: 10-K
Item: Item 16
Chunk 8
---

106

    10.23
    Registration Rights Agreement, dated as of May  5, 2024, by and among Plus Therapeutics, Inc., and the purchases named therein
     
    8-K
    001-34375Exhibit 10.3
    05/09/2024

    10.24
    Lending Agreement, dated April 5, 2024, by and between Plus Therapeutics, Inc and Pershing LLC
     
    8-K
    001-34375Exhibit 10.1
    06/04/2024

    10.25
    Loan Interest Rate Form, dated May 24, 2024, by and between Plus Therapeutics, Inc and Pershing LLC 
     
    8-K
    001-34375Exhibit 10.2
    06/04/2024

    10.26
    Extension of Credit, dated May 29, 2024, by and between Plus Therapeutics, Inc. and Pershing LLC
     
    8-K
    001-34375Exhibit 10.3
    06/04/2024

    10.27*
    Securities Purchase and Exchange Agreement, dated February 13, 2025, by and among Plus Therapeutics, Inc. and the purchasers named therein 
     
    8-K
    001-34375Exhibit 10.1
    02/18/2025

    10.28
    Form of Secured Convertible Note for Funding Notes issued pursuant to the Securities Purchase and Exchange Agreement, dated February 13, 2025, by and among Plus Therapeutics, Inc. and the purchasers names therein 
     
    8-K
    001-34375Exhibit 10.2
    02/18/2025

    10.29
    Form of Secured Convertible Note for Exchange Notes issued pursuant to the Securities Purchase and Exchange Agreement, dated February 13, 2025, by and among Plus Therapeutics, Inc. and the purchasers names therein 
     
    8-K
    001-34375Exhibit 10.3
    02/18/2025

    10.30*
    Security Agreement, dated February 13, 2025, by and among Plus Therapeutics